Ignite Creation Date:
2024-05-05 @ 10:20 PM
Last Modification Date:
2024-10-26 @ 10:17 AM
Study NCT ID:
NCT01088178
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2010-02-25
Brief Title:
Levonorgestrel-Intrauterine System LNG-IUS Insertion in the Postpartum Period
Sponsor:
United States Naval Medical Center Portsmouth
Organization:
United States Naval Medical Center Portsmouth
Study Overview
Official Title:
Levonorgestrel-Intrauterine System LNG-IUS Insertion in the Postpartum Period A Prospective Randomized Pilot Study of Three Time Intervals
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
Recruiting
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators study is a prospective randomized trial of women undergoing the levonorgestrel intrauterine system LNG-IUS Mirena Bayer at three separate time periods immediate post placental IPP defined as insertion within 10 min delivery of placenta early post partum EP defined as insertion after 10 min but within 72hrs postpartum or interval INT insertion defined as insertion after 6wks postpartum This is a pilot study in preparation for a multicenter prospective randomized study of long-acting reversible contraception in the postpartum period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None